314 related articles for article (PubMed ID: 15678518)
1. Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty.
Al MJ; Feenstra TL; Hout BA
Health Econ; 2005 Jul; 14(7):655-67. PubMed ID: 15678518
[TBL] [Abstract][Full Text] [Related]
2. Portfolio evaluation of health programs: a reply to Sendi et al.
Bridges JF; Terris DD
Soc Sci Med; 2004 May; 58(10):1849-51. PubMed ID: 15020002
[TBL] [Abstract][Full Text] [Related]
3. Ramsey waits: allocating public health service resources when there is rationing by waiting.
Gravelle H; Siciliani L
J Health Econ; 2008 Sep; 27(5):1143-54. PubMed ID: 18468707
[TBL] [Abstract][Full Text] [Related]
4. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
Al MJ; Feenstra T; Brouwer WB
Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
[TBL] [Abstract][Full Text] [Related]
5. Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations.
Sendi P; Al MJ; Gafni A; Birch S
Soc Sci Med; 2004 May; 58(10):1853-5. PubMed ID: 15020003
[TBL] [Abstract][Full Text] [Related]
6. Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources.
Sendi P; Al MJ; Gafni A; Birch S
Soc Sci Med; 2003 Dec; 57(11):2207-15. PubMed ID: 14512250
[TBL] [Abstract][Full Text] [Related]
7. Allocating health care resources when people are risk averse with respect to life time.
Hoel M
Health Econ; 2003 Jul; 12(7):601-8. PubMed ID: 12825211
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation in cardiology.
Maniadakis N; Vardas P; Mantovani LG; Fattore G; Boriani G
Europace; 2011 May; 13 Suppl 2():ii3-8. PubMed ID: 21518746
[TBL] [Abstract][Full Text] [Related]
9. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.
Baltussen RM; Hutubessy RC; Evans DB; Murray CJ
Int J Technol Assess Health Care; 2002; 18(1):112-9. PubMed ID: 11987434
[TBL] [Abstract][Full Text] [Related]
10. Application of cost-effectiveness analysis to multiple products: a practical guide.
Bala MV; Zarkin GA
Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
[TBL] [Abstract][Full Text] [Related]
11. Portfolio theory and cost-effectiveness analysis: a further discussion.
Sendi P; Al MJ; Rutten FF
Value Health; 2004; 7(5):595-601. PubMed ID: 15367254
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty.
Sendi P; Al MJ
Soc Sci Med; 2003 Sep; 57(6):969-74. PubMed ID: 12878098
[TBL] [Abstract][Full Text] [Related]
13. Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach.
Elbasha EH
Health Econ; 2005 May; 14(5):457-70. PubMed ID: 15386661
[TBL] [Abstract][Full Text] [Related]
14. [Cost-utility analysis; uncertainties restrict applicability].
de Neeling JN
Ned Tijdschr Geneeskd; 2004 May; 148(22):1106-10. PubMed ID: 15198066
[TBL] [Abstract][Full Text] [Related]
15. Role of budget impact in drug reimbursement decisions.
Cohen JP; Stolk E; Niezen M
J Health Polit Policy Law; 2008 Apr; 33(2):225-47. PubMed ID: 18325899
[TBL] [Abstract][Full Text] [Related]
16. Moving research into practice: A decision framework for integrating home telehealth into chronic illness care.
Hebert MA; Korabek B; Scott RE
Int J Med Inform; 2006 Dec; 75(12):786-94. PubMed ID: 16872892
[TBL] [Abstract][Full Text] [Related]
17. An economic approach to clinical trial design and research priority-setting.
Claxton K; Posnett J
Health Econ; 1996; 5(6):513-24. PubMed ID: 9003938
[TBL] [Abstract][Full Text] [Related]
18. Priority setting in health care: disentangling risk aversion from inequality aversion.
Echazu L; Nocetti D
Health Econ; 2013 Jun; 22(6):730-40. PubMed ID: 22736580
[TBL] [Abstract][Full Text] [Related]
19. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
20. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda.
Gafni A; Birch S
Soc Sci Med; 2006 May; 62(9):2091-100. PubMed ID: 16325975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
